Throughout the course of a medical diagnosis, members of your health care team will order different laboratory blood tests. Many times, these laboratory blood tests will be repeated throughout the diagnosis, treatment, follow-up, and continuing care. Each medical diagnosis and treatment has specific factors that are required to be monitored. When it comes to the results of these tests and what counts are normal or not, it is important to know that “normal” ranges simply reflect average values in a population. It is common for some tests to be slightly outside of the “normal range” (low or high) without consequence and your clinicians can guide you with respect to their relevance.
Chances are, if you have breast cancer you’ve heard about Tamoxifen. I remember the first time my oncologist talked to me about the chemo-infused hormonal-therapy drug. It was during my weekly check-up when I was still having daily radiation. He explained that because the cancer cells found in my right breast were 95 per cent estrogen and progesterone receptor positive, my body’s natural hormones could attach to the cancer cells and help them grow. Obviously I didn’t want that, so I said yes to the drug without even hesitating.
Breastfeeding has been linked to a few health benefits such as its ability to reduce the risk of being diagnosed with breast cancer. This may be because of reduced exposure to estrogen as well as the shedding of breast tissue. But what happens when breastfeeding cannot reduce your risk of breast cancer because you have already been diagnosed? While breastfeeding comes with its own challenges, having a newborn while dealing with a breast cancer diagnosis comes with its own unique complications. One of these is knowing whether you can breastfeed your child and how to go about it.
I hope I can write this column without crying. Or at least if I do get emotional, that I won’t need to stop a million times while I wait for the sobbing to ease up so that I can see clearly enough to continue typing. And no, I’m not being dramatic.
CBCN produces curated magazines that focus on topics that are relevant to the breast cancer community. These magazines provide patients with an easy-to-access method of getting information on various breast-cancer-related topics. The articles featured in our magazine are pulled from Our Voices blog and are created so that breast cancer patients can access certain themes/topics in one place.
The risk of a COVID-19 diagnosis for breast cancer patients is still not completely known. Studies have come that show that cancer patients are more at risk of adverse effects if they develop COVID-19. However, a few studies state that compared to other cancer patients, breast cancer patients are at a lower risk of serious illness. The stage of breast cancer also seems to play a role in one’s risk level.
Individuals diagnosed with cancer have been identified as being at a high-risk of getting seriously ill if they get COVID-19. Data from various studies show that the type of cancer, the stage, the person’s age, health, and other factors contribute to how high-risk a patient may be. In addition to this, the type of treatment a person is receiving and how long their last treatment was, can all impact their outcome. At the same time, a few studies have shown that breast cancer patients fare better, compared to patients with other types of cancers.
For Jenn Abbott, finishing treatment for breast cancer is like a flying trapeze. Having received her “NED” (no evidence of disease), she is in mid-air, no longer holding on to the bar that represents the medical team that saved her life, while at the same time, not yet catching the second bar that represents the rest of her life after cancer. She is in limbo, facing post-traumatic stress disorder brought on by her cancer treatment which included five surgeries and a severe adverse reaction to chemotherapy that meant she had to stay in the hospital for two weeks. She feels PTSD after cancer treatment is real.
Febrile neutropenia, or FN, is a common and potentially serious side effect of chemotherapy treatment.
In August 2016, Erin Richard of Sydney, Nova Scotia was diagnosed with triple negative metastatic breast cancer. She was only 39 years old.
Because fatigue is a predominant symptom of cancer, CBCN reached out to Georden Jones for advice on managing this symptom. Georden is a doctoral student in clinical psychology at the University of Ottawa. Her thesis focuses on cancer-related fatigue, in particular on the patient's experience with this symptom and how to implement assessment and interventions programs for cancer-related fatigue. Her thesis project is ongoing and is estimated to end by 2019. If you have any questions concerning her work, please do not hesitate to contact her by email: email@example.com.